Review

. 2017 Sep;11(3):191-196.

doi: 10.1097/SPC.0000000000000288.

Current directions in research and treatment of fear of cancer recurrence

Louise Sharpe¹, Belinda Thewes, Phyllis Butow

Affiliations

Affiliation

¹ aSchool of Psychology, The University of Sydney, Sydney, New South Wales, Australia bDepartment of Medical Psychology, Radboud University Medical Centre, Nijmegen, The Netherlands cPsycho-Oncology Co-operative Research Group, The University of Sydney, Sydney, New South Wales, Australia.

PMID: 28665813
DOI: 10.1097/SPC.0000000000000288

Review

Current directions in research and treatment of fear of cancer recurrence

Louise Sharpe et al. Curr Opin Support Palliat Care. 2017 Sep.

. 2017 Sep;11(3):191-196.

doi: 10.1097/SPC.0000000000000288.

Authors

Louise Sharpe¹, Belinda Thewes, Phyllis Butow

Affiliation

¹ aSchool of Psychology, The University of Sydney, Sydney, New South Wales, Australia bDepartment of Medical Psychology, Radboud University Medical Centre, Nijmegen, The Netherlands cPsycho-Oncology Co-operative Research Group, The University of Sydney, Sydney, New South Wales, Australia.

PMID: 28665813
DOI: 10.1097/SPC.0000000000000288

Abstract

Purpose of review: An expert meeting in Ottawa in 2015 galvanized efforts to answer key questions relevant to the understanding and management of fear of cancer recurrence (FCR). The aim of this review is to summarize key developments.

Recent findings: A consensus on the definition of FCR has helped to further research in this area. There have been a number of theories put forward to account for the development of FCR, all of which share key components. Importantly, a number of important trials have been published that confirm both brief and more intensive interventions can successfully treat FCR.

Summary: The consensus definition of FCR is an important development, as is the development of treatments for FCR. There are now evidence-based options for the management of patients with clinical levels of FCR. Future research priorities include determining the optimal cut-off points for identifying clinically significant FCR, testing the major tenets of the recent theoretical formulations of FCR; and determining the relative efficacy and cost-effectiveness of different treatment approaches for managing FCR.

PubMed Disclaimer

Cited by

Home-based cognitive bias modification training for reducing maladaptive fear in patients with suspected acute coronary syndrome: a pilot randomized clinical trial.
Lopez-Veneros D, Cumella R, Kronish IM, Lazarov A, Birk JL. Lopez-Veneros D, et al. Pilot Feasibility Stud. 2024 Jan 11;10(1):7. doi: 10.1186/s40814-024-01442-2. Pilot Feasibility Stud. 2024. PMID: 38212853 Free PMC article.
The bodily threat monitoring scale: Development and preliminary validation in adult and childhood cancer survivors.
Heathcote LC, Webster SN, Loecher N, Spunt SL, Simon P, Pradhan P, Coutts-Bain D, Sharpe L, Tutelman PR, Simons LE. Heathcote LC, et al. Psychooncology. 2023 Dec;32(12):1885-1894. doi: 10.1002/pon.6236. Epub 2023 Nov 2. Psychooncology. 2023. PMID: 37916988
Efficacy of eye movement desensitization and reprocessing therapy for fear of cancer recurrence among cancer survivors: a randomized single-case experimental design.
Bruin J, van Rood YR, Peeters KCMJ, de Roos C, Tanious R, Portielje JEA, Gelderblom H, Hinnen SCH. Bruin J, et al. Eur J Psychotraumatol. 2023;14(2):2203427. doi: 10.1080/20008066.2023.2203427. Eur J Psychotraumatol. 2023. PMID: 37144665 Free PMC article. Clinical Trial.
Fear-focused Self-compassion Therapy for young breast cancer patients' fear of cancer recurrence: Study protocol of a randomized controlled trial.
Wei L, Yang X, Sun S, Yu Y, Xie J, Zhao J, Wang X, Zhu L, Yao J. Wei L, et al. Front Psychiatry. 2022 Sep 23;13:941459. doi: 10.3389/fpsyt.2022.941459. eCollection 2022. Front Psychiatry. 2022. PMID: 36213912 Free PMC article.
Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study.
Howell DM, Metcalfe K, Kong S, Stephen J, Olivotto IA, Baxter N, Friedenreich CM, Warner E, Akbari MR, McBain K, Narod S, Quan ML. Howell DM, et al. Breast Cancer Res Treat. 2022 Jul;194(1):91-102. doi: 10.1007/s10549-022-06576-6. Epub 2022 Apr 24. Breast Cancer Res Treat. 2022. PMID: 35462611

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Current directions in research and treatment of fear of cancer recurrence

Affiliation

Current directions in research and treatment of fear of cancer recurrence

Authors

Affiliation

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials